Partnerships & Growth

• Breakthrough innovation at HealioScan is driven by strategic collaboration with leading academic, research, and industry partners.
• Partnerships with Vanderbilt University, NVIDIA, and Y Combinator reinforce our technological foundation and accelerate innovation.
• These alliances support rigorous validation, scalable infrastructure, and global readiness for PAMLEE™ deployment.
• By uniting academic research, advanced computing, and startup agility, HealioScan is advancing a future where early cancer detection becomes the global standard.

No breakthrough happens in isolation. At HealioScan, our vision for AI-powered cancer detection is made possible through partnerships with leading institutions, research organizations, and industry giants.

We are proud to highlight collaborations with Vanderbilt University, NVIDIA, and Y Combinator, which strengthen our technological backbone and provide platforms for accelerated innovation.

These partnerships help us validate our technology, ensure scalability, and prepare PAMLEE for global deployment. By combining academic research, advanced computing, and startup agility, HealioScan is uniquely positioned to make a lasting impact in healthcare.

Together, we’re building a future where early cancer detection is the standard, not the exception.